Micro Interventional Devices, Inc.™ Successfully Treats First-in-Human Patient with Percutaneous MIA™

Micro Interventional Devices, Inc.™ (MID) announced today the world's first percutaneous implantation of its MIA™, Minimally Invasive Annuloplasty, technology for tricuspid and mitral repair, which marks the first patient enrolled in the transcatheter arm of the STTAR trial.